Equities research analysts expect that LifePoint Health Inc (NASDAQ:LPNT) will announce earnings per share of $0.81 for the current quarter, Zacks Investment Research reports. Nine analysts have issued estimates for LifePoint Health’s earnings, with the highest EPS estimate coming in at $0.91 and the lowest estimate coming in at $0.74. LifePoint Health reported earnings per share of $1.09 in the same quarter last year, which suggests a negative year over year growth rate of 25.7%. The business is scheduled to report its next quarterly earnings results on Friday, February 16th.
According to Zacks, analysts expect that LifePoint Health will report full-year earnings of $3.67 per share for the current fiscal year, with EPS estimates ranging from $3.56 to $4.01. For the next financial year, analysts anticipate that the business will post earnings of $4.01 per share, with EPS estimates ranging from $3.53 to $4.60. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research firms that cover LifePoint Health.
LifePoint Health (NASDAQ:LPNT) last posted its earnings results on Friday, October 27th. The company reported $0.80 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.95 by ($0.15). LifePoint Health had a return on equity of 7.01% and a net margin of 2.45%. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.60 billion. During the same period in the previous year, the company earned $0.94 earnings per share. The company’s revenue was down .7% compared to the same quarter last year.
Several research firms have recently issued reports on LPNT. Zacks Investment Research raised shares of LifePoint Health from a “sell” rating to a “hold” rating in a research note on Monday, September 11th. Robert W. Baird set a $69.00 target price on shares of LifePoint Health and gave the stock a “buy” rating in a research note on Thursday, October 12th. Raymond James Financial reissued a “market perform” rating on shares of LifePoint Health in a research note on Monday, October 30th. Credit Suisse Group began coverage on shares of LifePoint Health in a research note on Thursday, November 2nd. They set a “neutral” rating and a $54.00 target price on the stock. Finally, William Blair reissued an “outperform” rating on shares of LifePoint Health in a research note on Tuesday, November 21st. Three investment analysts have rated the stock with a sell rating, twelve have given a hold rating and five have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $59.14.
In related news, Director Marguerite Kondracke sold 3,416 shares of the firm’s stock in a transaction dated Tuesday, November 21st. The shares were sold at an average price of $43.80, for a total value of $149,620.80. Following the transaction, the director now directly owns 17,479 shares of the company’s stock, valued at approximately $765,580.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 8.76% of the company’s stock.
Institutional investors have recently modified their holdings of the stock. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in LifePoint Health by 10.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after buying an additional 164 shares in the last quarter. Shelton Capital Management purchased a new position in LifePoint Health in the 2nd quarter valued at about $205,000. Capstone Investment Advisors Netherlands B.V. purchased a new position in LifePoint Health in the 2nd quarter worth approximately $233,000. Airain ltd purchased a new position in LifePoint Health in the 2nd quarter worth approximately $234,000. Finally, Commerce Bank purchased a new position in LifePoint Health in the 2nd quarter worth approximately $309,000. 99.18% of the stock is currently owned by hedge funds and other institutional investors.
Shares of LifePoint Health (NASDAQ:LPNT) opened at $47.55 on Wednesday. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.65 and a current ratio of 1.85. LifePoint Health has a 12 month low of $42.50 and a 12 month high of $70.95. The stock has a market cap of $1,891.96, a PE ratio of 12.24, a PEG ratio of 1.13 and a beta of 0.67.
LifePoint Health declared that its Board of Directors has authorized a share buyback plan on Friday, October 27th that authorizes the company to repurchase $200.00 million in outstanding shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase plans are generally a sign that the company’s management believes its stock is undervalued.
COPYRIGHT VIOLATION NOTICE: “$0.81 EPS Expected for LifePoint Health Inc (LPNT) This Quarter” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/01/13/0-81-eps-expected-for-lifepoint-health-inc-lpnt-this-quarter.html.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Get a free copy of the Zacks research report on LifePoint Health (LPNT)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.